en

PRODUCT DETAIL

Livmarli 9,5 mg/ml perorálny roztok

Code 2617E
MA number EU/1/22/1704/001
Product Form: sol por 1x30 ml/285 mg (fľ.PET)
MA Status: Ev - Valid centralised marketing authorisation under exceptional circumstances
Type of procedure: EU Orphan
Therapeutic Class: 43 - CHOLERETICA, CHOLEKINETICA
ATC:
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AX Other drugs for bile therapy
A05AX04 Maralixibat chloride
Shelf life: 30
Container: bottle polyethylene terephtalate (PET)
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 09.12.2022
Validity: 09.12.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 14.08.2023
eu-flag.png sk-flag.png